In a more recent gene expression study encompassing healthy controls, advanced AD (Braak stage III–VI), frontotemporal dementia, and Huntington’s disease (GSE110226), OR2K2 was indeed found to be expressed in the CP. Here, OR2K2 is linked to juvenile Huntington disease.